Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001644250-15-000010)

Filing Details

Accession Number:
0001644250-15-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-04 18:01:10
Reporting Period:
2015-12-03
Filing Date:
2015-12-04
Accepted Time:
2015-12-04 18:01:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seattle Genetics Inc SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1167496 B Clay Siegall 21823 30Th Drive Se
Bothell WA 98021		 President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-03 3,720 $5.63 559,835 No 4 M Direct
Common Stock Disposition 2015-12-03 3,720 $39.99 556,115 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-12-03 3,720 $0.00 3,720 $5.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-01-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 27,945 Indirect by Trust
Footnotes
  1. The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan.
  2. Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
  3. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
  4. Shares vested at a rate of 25% on 1/31/07 and monthly thereafter until all the shares were fully vested on 1/31/10.